Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,088 | -1,058 | -7,631 | -4,563 | -4,361 |
| Depreciation Amortization | 119 | 60 | 175 | 382 | 243 |
| Accounts receivable | N/A | N/A | N/A | -546 | -788 |
| Other Working Capital | 8 | 28 | -81 | -2,041 | -1,949 |
| Other Operating Activity | 31 | 18 | 5,948 | 5,131 | 4,817 |
| Operating Cash Flow | $-1,930 | $-952 | $-1,589 | $-1,637 | $-2,038 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -152 | -320 | -278 |
| Investing Cash Flow | $N/A | $N/A | $-152 | $-320 | $-278 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 3,750 | 3,750 | 3,750 |
| Debt Repayment | N/A | N/A | -2,650 | -2,741 | -2,302 |
| Common Stock Issued | 5 | 4 | 650 | 650 | 650 |
| Other Financing Activity | 0 | 0 | -36 | -36 | -25 |
| Financing Cash Flow | $5 | $4 | $1,714 | $1,623 | $2,073 |
| Beginning Cash Position | 4,717 | 4,717 | 35 | 416 | 416 |
| End Cash Position | 2,792 | 3,769 | 8 | 83 | 174 |
| Net Cash Flow | $-1,925 | $-948 | $-27 | $-334 | $-242 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,930 | -952 | -1,589 | -1,637 | -2,038 |
| Capital Expenditure | N/A | N/A | -152 | -320 | -278 |
| Free Cash Flow | -1,930 | -952 | -1,741 | -1,957 | -2,316 |